Mayumi Imahashi

579 total citations
26 papers, 401 citations indexed

About

Mayumi Imahashi is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Mayumi Imahashi has authored 26 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 13 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Mayumi Imahashi's work include HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (9 papers). Mayumi Imahashi is often cited by papers focused on HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (9 papers). Mayumi Imahashi collaborates with scholars based in Japan, Australia and United States. Mayumi Imahashi's co-authors include Yasumasa Iwatani, Yoshiyuki Yokomaku, Hirotaka Ode, Wataru Sugiura, Kazuhiro Matsuoka, Nobuhisa Watanabe, Yoshihiro Nakata, Takashi Yamane, Shingo Kitamura and Atsuo Suzuki and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Mayumi Imahashi

21 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mayumi Imahashi Japan 9 204 184 169 103 83 26 401
Carlos Rocco Argentina 13 192 0.9× 243 1.3× 123 0.7× 77 0.7× 99 1.2× 28 424
Daniëlle van Manen Netherlands 10 162 0.8× 307 1.7× 101 0.6× 94 0.9× 190 2.3× 16 423
Víctor Sánchez-Merino Spain 13 255 1.3× 343 1.9× 72 0.4× 81 0.8× 112 1.3× 26 442
Abraham J. Kandathil United States 11 194 1.0× 237 1.3× 49 0.3× 152 1.5× 72 0.9× 26 427
Deborah King United Kingdom 13 103 0.5× 181 1.0× 114 0.7× 59 0.6× 134 1.6× 25 400
Benjamin N. Greener United States 7 175 0.9× 131 0.7× 112 0.7× 93 0.9× 58 0.7× 8 321
María del Mar González Spain 15 316 1.5× 285 1.5× 175 1.0× 147 1.4× 45 0.5× 24 555
Daniëlla Mortier Netherlands 11 110 0.5× 122 0.7× 74 0.4× 212 2.1× 149 1.8× 21 420
Eduardo Seclén Spain 11 247 1.2× 265 1.4× 59 0.3× 102 1.0× 72 0.9× 18 375

Countries citing papers authored by Mayumi Imahashi

Since Specialization
Citations

This map shows the geographic impact of Mayumi Imahashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayumi Imahashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayumi Imahashi more than expected).

Fields of papers citing papers by Mayumi Imahashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayumi Imahashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayumi Imahashi. The network helps show where Mayumi Imahashi may publish in the future.

Co-authorship network of co-authors of Mayumi Imahashi

This figure shows the co-authorship network connecting the top 25 collaborators of Mayumi Imahashi. A scholar is included among the top collaborators of Mayumi Imahashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayumi Imahashi. Mayumi Imahashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adachi, Eisuke, Rumi Minami, Michinori Shirano, et al.. (2025). Evaluation of cabotegravir plus rilpivirine in routine clinical settings in Japan: A multicentre study of efficacy, safety and biomarker dynamics. HIV Medicine. 26(11). 1673–1683.
2.
Hill, Adam O., Gregory Armstrong, Mayumi Imahashi, et al.. (2025). Gay Networks, Greater Happiness? Associations Between Gay and Heterosexual Social Capital and Subjective Happiness Among MSM in Japan. Social Sciences. 14(6). 381–381.
3.
Iwatani, Yasumasa, Kazuhiro Matsuoka, Hirotaka Ode, et al.. (2025). The unique structure of the highly conserved PPLP region in HIV-1 Vif is critical for the formation of APOBEC3 recognition interfaces. mBio. 16(3). e0333224–e0333224. 1 indexed citations
4.
Hill, Adam O., et al.. (2025). High suicidality rates among LGB+ youth in Japan: Demographic and psychosocial correlates. Journal of Affective Disorders. 387. 119468–119468.
5.
Ode, Hirotaka, Masakazu Matsuda, Yoshihiro Nakata, et al.. (2024). Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations. Scientific Reports. 14(1). 12099–12099. 6 indexed citations
6.
Nakata, Yoshihiro, Hirotaka Ode, Kazuhiro Matsuoka, et al.. (2023). Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome. Nucleic Acids Research. 51(2). 783–795. 34 indexed citations
7.
8.
Ode, Hirotaka, Yoshihiro Nakata, Masakazu Matsuda, et al.. (2022). Nanopore Sequencing for Characterization of HIV-1 Recombinant Forms. Microbiology Spectrum. 10(4). e0150722–e0150722. 7 indexed citations
9.
Matsuoka, Kazuhiro, Nobuhiko Imahashi, Hirotaka Ode, et al.. (2022). SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer. Journal of Biological Chemistry. 298(3). 101724–101724. 30 indexed citations
10.
Matsuda, Masakazu, Shiro Ibe, Michiko Nemoto, et al.. (2022). Evaluation of the Geenius HIV 1/2 confirmatory assay for HIV-2 samples isolated in Japan. Journal of Clinical Virology. 152. 105189–105189. 1 indexed citations
11.
Imahashi, Mayumi, et al.. (2021). Retrospective Analysis of the Efficacy of Early Antiretroviral Therapy in HIV-1-Infected Patients Coinfected with Pneumocystis jirovecii. AIDS Research and Human Retroviruses. 37(10). 754–760. 2 indexed citations
12.
Imahashi, Mayumi, Hirotaka Ode, Ayumi Kobayashi, et al.. (2021). Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients. Scientific Reports. 11(1). 960–960. 49 indexed citations
13.
Ode, Hirotaka, Ayumi Kobayashi, Masakazu Matsuda, et al.. (2019). Identifying integration sites of the HIV-1 genome with intact and aberrant ends through deep sequencing. Journal of Virological Methods. 267. 59–65. 5 indexed citations
14.
Imahashi, Mayumi, Kayo Fujimoto, Lisa M. Kuhns, Muhammad Amith, & John A. Schneider. (2019). Network overlap and knowledge of a partner’s HIV status among young men who have sex with men. AIDS Care. 31(12). 1533–1539. 6 indexed citations
15.
Nagae, T., Hirotaka Ode, Kazuhiro Matsuoka, et al.. (2018). Structural basis of chimpanzee APOBEC3H dimerization stabilized by double-stranded RNA. Nucleic Acids Research. 46(19). 10368–10379. 25 indexed citations
16.
Imahashi, Mayumi & Yoshiyuki Yokomaku. (2018). Middle-aged man with symmetrical lesions in his throat. European Journal of Internal Medicine. 55. e7–e8. 1 indexed citations
17.
Imahashi, Mayumi, T Izumi, Dai Watanabe, et al.. (2014). Lack of Association between Intact/Deletion Polymorphisms of the APOBEC3B Gene and HIV-1 Risk. PLoS ONE. 9(3). e92861–e92861. 22 indexed citations
18.
Imahashi, Mayumi, et al.. (2012). Antiviral Mechanism and Biochemical Basis of the Human APOBEC3 Family. Frontiers in Microbiology. 3. 250–250. 34 indexed citations
19.
Bunupuradah, Torsak, Mayumi Imahashi, Kazuhiro Matsuoka, et al.. (2012). Association of APOBEC3G genotypes and CD4 decline in Thai and Cambodian HIV-infected children with moderate immune deficiency. AIDS Research and Therapy. 9(1). 34–34. 13 indexed citations
20.
Kitamura, Shingo, Hirotaka Ode, Mayumi Imahashi, et al.. (2012). The APOBEC3C crystal structure and the interface for HIV-1 Vif binding. Nature Structural & Molecular Biology. 19(10). 1005–1010. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Rocco Breakdown of academic impact, for papers by Daniëlle van Manen Breakdown of academic impact, for papers by Víctor Sánchez-Merino Breakdown of academic impact, for papers by Abraham J. Kandathil Breakdown of academic impact, for papers by Deborah King Breakdown of academic impact, for papers by Benjamin N. Greener Breakdown of academic impact, for papers by María del Mar González Breakdown of academic impact, for papers by Daniëlla Mortier Breakdown of academic impact, for papers by Eduardo Seclén
Rankless by CCL
2026